Cargando…
Drug Discovery of Host CLK1 Inhibitors for Influenza Treatment
The rapid evolution of influenza virus makes antiviral drugs less effective, which is considered to be a major bottleneck in antiviral therapy. The key proteins in the host cells, which are related with the replication cycle of influenza virus, are regarded as potential drug targets due to their dis...
Autores principales: | Zu, Mian, Li, Chao, Fang, Jian-Song, Lian, Wen-Wen, Liu, Ai-Lin, Zheng, Li-Shu, Du, Guan-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332427/ https://www.ncbi.nlm.nih.gov/pubmed/26540031 http://dx.doi.org/10.3390/molecules201119653 |
Ejemplares similares
-
SGC-CLK-1: A chemical probe for the Cdc2-like kinases CLK1, CLK2, and CLK4
por: Tiek, Deanna, et al.
Publicado: (2023) -
Targeting the trypanosome kinetochore with CLK1 protein kinase inhibitors
por: Saldivia, Manuel, et al.
Publicado: (2020) -
Controlling clots with Clk1
por: Williams, Ruth
Publicado: (2006) -
CLK1/CLK2-driven signalling at the Leishmania kinetochore is captured by spatially referenced proximity phosphoproteomics
por: Geoghegan, Vincent, et al.
Publicado: (2022) -
Specific CLK Inhibitors from a Novel Chemotype for Regulation of Alternative Splicing
por: Fedorov, Oleg, et al.
Publicado: (2011)